7th Circ. Revives Suit Over Abbott Off-Label Scheme
The Seventh Circuit on Monday revived a proposed class action from employer health insurance plans targeting Abbott Laboratories' promotion of seizure drug Depakote for off-label uses, finding that a district judge...To view the full article, register now.
Already a subscriber? Click here to view full article